Vodcast seriesRewrite the Rules
In this vodcast series, we aim to inspire not just you, but the entire biopharmaceutical community. With insights from leading scientists around the world, it’s an invitation to reshape and rewrite the rules of your laboratory.
On or off target? Looking beyond the expected
with Hugo Gagnon, PhD, Chief Scientific Officer, Allumiqs
In this episode, we take a deep dive into what gene editing is and uncover why establishing analytics for gene editing is such a complex task.
Get a glimpse with our episode previews. Unlock the full experience by signing up.
Subscribe today for exclusive access to full episodes and stay updated on new releases.
Our past episodes:
Answering the question - what's under that peak?
with Kristen Nields, PhD, Senior Scientist, Janssen
In this episode, we explore the challenges in charge variant analysis and how to address the bottlenecks with new workflow approaches.
The team viral vectors
with Jill Bradley-Graham, PhD, Senior Scientist, Gene and Cell Therapy BioAnalytics, Sanofi
In this episode, we discuss why viral vector characterization is particularly challenging and how collaboration is key for newly emerging fields.
Explore the potential of mRNA
with Jérémie Parot, PhD, Research Scientist, SINTEF
In this episode, we explore the difficulties faced when characterizing mRNA and the opportunities that mRNA research brings to medicine.
Dealing with surprises
with Tyler Heibeck, PhD, Principal Scientist, Sutro Biopharma
In this episode, we talk about the surprises and challenges encountered in drug development and how new analytical approaches may help find the answer.
The “personality” of oligonucleotides
with Shane Karnik, Senior Laboratory Director, Aliri Bioanalysis
In this episode, we discuss what bioanalysis is and how bioanalysis of oligonucleotides differs from that of other modalities.
Solving the HCP puzzle with mass spectrometry
with Thomas Kofoed, PhD, Co-founder and CEO, Alphalyse
In this episode, we chat about host cell proteins (HCPs), the importance of their analysis in cell and gene therapy products and the challenges of this field.